(688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Share Repurchase Plan through Call Auction
Filed with SSE · Stock code 688578 · · 9 pages · Chinese
Summary by 6ix AI
Shanghai Allist Pharmaceuticals Co. Ltd. has announced a share repurchase plan through a call auction, detailing the purpose and method of the buyback. The plan aims to enhance investor confidence and support employee stock ownership initiatives. The repurchase will be conducted using the company's own funds, with a specified price limit and total amount allocated for the buyback. The company has outlined potential risks associated with the repurchase, including market price fluctuations and regulatory changes.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Story so far
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress of the Pivotal Clinical Trial of Furmonertinib for First-line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Proposal by the Actual Controller, Chairman and General Manager to Repurchase Company Shares
- Announcement on Voluntary Disclosure of the Acceptance of Marketing Application for a New Indication of Furmonertinib Mesilate Tablets
Earlier from Shanghai Allist Pharmaceuticals
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Proposal by the Actual Controller, Chairman and General Manager to Repurchase Company Shares
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress of the Pivotal Clinical Trial of Furmonertinib for First-line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
- Announcement on Voluntary Disclosure of the Acceptance of Marketing Application for a New Indication of Furmonertinib Mesilate Tablets
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
Later from Shanghai Allist Pharmaceuticals
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Initial Repurchase of Shares through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals